Skip to content

Clinical trials

Recruiting Phase 1/2 Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 1/2 Status: Recruiting Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20241
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China1
CRISPR Therapeutics AG1
Climb Bio, Inc.1
Eli Lilly and Company1
Institute of Hematology & Blood Diseases Hospital, China1
Jiangsu BioJeTay Biotechnology Co., Ltd.1
Keymed Biosciences Co.Ltd1
Renata PLC1
Shanghai Escugen Biotechnology Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic9
Anemia, Hemolytic, Autoimmune1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.